Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 2/20 | 0.47 |
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | TDO2 | P48775 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.38 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.35 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8955219 | 0.86 | CA12 (0.35) | AOC3SLC6A4ALDH1A1CYP1A2CYP2D6 | |
| SCHEMBL17789906 | 0.81 | SLC6A4 (0.42) | AOC3IDO1TDO2SLC6A2SLC6A4 | |
| SCHEMBL792136 | 0.79 | IDO1 (0.58) | AOC3IDO1TDO2ACHESLC6A2 | |
| SCHEMBL15350067 | 0.78 | TSHR (0.34) | ALDH1A1TSHR | |
| SCHEMBL21162070 | 0.78 | TSHR (0.34) | ALDH1A1TSHR | |
| SCHEMBL12784519 | 0.77 | AOC3 (0.46) | AOC3IDO1TDO2ACHESLC6A2 | |
| SCHEMBL13929388 | 0.77 | AOC3 (0.46) | AOC3IDO1TDO2ACHESLC6A2 | |
| SCHEMBL250661 | 0.76 | IDO1 (0.43) | IDO1NFE2L2ALDH1A1HTTHDAC4 | |
| SCHEMBL2431139 | 0.76 | ACHE (0.44) | ACHEALDH1A1MAPT | |
| SCHEMBL6206391 | 0.75 | AOC3 (0.44) | AOC3IDO1TDO2ACHESLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140323705-A1 | MANUFACTURE OF LACTO-N-TETRAOSE | GLYCOM A/S (DK) | 2014-10-30 | — | — | US | disclosed |
| CN-104024239-A | BENZYL SULFONAMIDE DERIVATIVES AS RORc MODULATORS | HOFFMANN LA ROCHE | 2014-09-03 | — | — | CN | disclosed |
| EP-1506175-A1 | N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2005-02-16 | — | — | EP | disclosed |
| WO-2003097609-A1 | N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2003-11-27 | — | — | WO | disclosed |
| EP-0393668-B1 | Method of preparation of benzaldehyde dialkyl acetals and new benzaldehyde dialkyl acetals | BASF AG (DE) | 1994-02-02 | — | — | EP | disclosed |
| EP-0393667-B1 | PROCESS FOR THE PRODUCTION OF BENZYL METHYL ESTERS | BASF Aktiengesellschaft (DE) | 1993-06-23 | — | — | EP | disclosed |
| US-5078838-A | By electrochemical anodic oxidation of benzyl derivatives in the presence of an aliphatic alcohol | BASF AKTIENGESELLSCHAFT (DE) | 1992-01-07 | — | — | US | disclosed |
| EP-0393668-A2 | Method of preparation of benzaldehyde dialkyl acetals and new benzaldehyde dialkyl acetals | BASF Aktiengesellschaft (DE) | 1990-10-24 | — | — | EP | disclosed |
| EP-0393667-A1 | Process for the production of benzyl methyl esters | BASF Aktiengesellschaft (DE) | 1990-10-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140323705-A1 | MANUFACTURE OF LACTO-N-TETRAOSE | FUT6, FUT5, ST6GAL1 | AOC3 2722/4885IDO1 1801/4885TDO2 376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.